PHARMACISTS INTERVENTION REDUCED DRUG-RELATED PROBLEMS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS

Abstract

estimated 463 million (9.3%) of the world's population in adults aged 20-79 years suffering from diabetes. Without sufficient action, it was estimated that 578 million people (10.2% of the population) will have diabetes by 2030. Indonesia ranked 7th country in the world with the number of diabetics (10.7 million), estimated to increase to 13.7 million in 2030. Effective diabetes management often presented big challenges. One of the things that can prevent or delay patients from achieving the goals of T2DM therapy was related to drug therapy or known as drug-related problems (DRP's). Pharmacist clinical intervention can have a positive impact on patient treatment. Pharmacist intervention was always considered valuable involvement by the health care community in the process of patient treatment in reducing medication error, rationalizing therapy and reducing therapy cost. Objectives: This study aimed to identify and review original articles in evaluating pharmacist intervention in the management of diabetes mellitus on drug-related problems (DRP). Methods: Review the PubMed and ProQuest database to identify management evaluation of T2DM therapy. The inclusion criteria used in this study were all original research articles published between 1999 until 2017 regarding pharmacist interventions on DRP. Articles were assessed using the Prisma checklist. Results: 4 articles related to this study. Patients with T2DM were at risk of experiencing drug-related problems (DRP), which can occur at every step during the treatment process and affect the result of therapy. The average DRP value were quite high at 4.1 to 4.6 DRP per patient. Conclusions: Pharmacist interventions helped increase the quality of treatment and reduced health care costs. Patient education and counseling from pharmacists to identify and resolve drug-related problems (DRP) and improve treatment compliance can help achieve the goals of managing diabetes mellitus therapy.